These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35521766)

  • 1. Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism.
    Taskinen MR; Matikainen N; Björnson E; Söderlund S; Ainola M; Hakkarainen A; Lundbom N; Sihlbom C; Thorsell A; Andersson L; Adiels M; Hartmann B; Deacon CF; Holst JJ; Packard CJ; Borén J
    Eur J Endocrinol; 2022 May; 187(1):75-84. PubMed ID: 35521766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
    J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging regulators of intestinal lipoprotein secretion.
    Xiao C; Dash S; Morgantini C; Lewis GF
    Atherosclerosis; 2014 Apr; 233(2):608-615. PubMed ID: 24534456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients.
    Dalgaard M; Thomsen C; Rasmussen BM; Holst JJ; Hermansen K
    Metabolism; 2004 Jan; 53(1):77-83. PubMed ID: 14681846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
    Taskinen MR; Björnson E; Matikainen N; Söderlund S; Pietiläinen KH; Ainola M; Hakkarainen A; Lundbom N; Fuchs J; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
    Diabetes Obes Metab; 2021 May; 23(5):1191-1201. PubMed ID: 33502078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.
    Lu WJ; Yang Q; Yang L; Lee D; D'Alessio D; Tso P
    Lipids; 2012 Jun; 47(6):571-80. PubMed ID: 22297815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
    Thomsen C; Storm H; Holst JJ; Hermansen K
    Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states.
    Farr S; Adeli K
    Curr Opin Lipidol; 2012 Feb; 23(1):56-61. PubMed ID: 22123671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gastric bypass surgery on postprandial gut and systemic lipid handling.
    Jegatheesan P; Seyssel K; Stefanoni N; Rey V; Schneiter P; Giusti V; Lecoultre V; Tappy L
    Clin Nutr ESPEN; 2020 Feb; 35():95-102. PubMed ID: 31987128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incretins and Lipid Metabolism.
    Tsimihodimos V; Elisaf M
    Curr Med Chem; 2018; 25(18):2133-2139. PubMed ID: 28413961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylomicrons stimulate incretin secretion in mouse and human cells.
    Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
    Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
    Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K
    Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.
    Alssema M; Rijkelijkhuizen JM; Holst JJ; Teerlink T; Scheffer PG; Eekhoff EM; Gastaldelli A; Mari A; Hart LM; Nijpels G; Dekker JM
    Eur J Endocrinol; 2013 Oct; 169(4):421-30. PubMed ID: 23864340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states.
    Hein GJ; Baker C; Hsieh J; Farr S; Adeli K
    Diabetes; 2013 Feb; 62(2):373-81. PubMed ID: 23028139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.